HEALTHCARE

Azura’s lead compound AZR-MD-001 is a topical ointment applied to the lower lid that has shown a positive safety and efficacy profile.

Prime Minister Benjamin Netanyahu: Israel had the highest infection rate in the world and today we have almost the lowest.

The sale in equal shares to The Phoenix Holdings and Leumi Partners is at a valuation of $140 million.

The Levinstein group was to have bought the Har Hotzvim property for NIS 171 million.

Mileutis is in advanced stages of development of an innovative product which addresses bovine mastitis, the main concern in the dairy industry.

Scentech with which NextGen Biomed is merging, has successfully identified Covid-19 biomarkers through gas compounds.

CEO Dr. Liat Goldshaid-Zmiri describes how a casual e-mail led to aesthetic medicine company Luminera's acquisition by AbbVie.

Israel's National Coronavirus Project Coordinator Prof. Ronni Gamzu will recommend opening businesses that do not receive the public, and resumption of early childhood education.

The former Teva Israel CEO, now CEO of Tikun Olam Cannbit, talks about the business and therapeutic potential of medical cannabis.

The Israeli company's medical coding speeds up billing by automatically assigning the most accurate medical codes required for medical reimbursement.

The EU has an agreement to procure 400 million vaccinations from AstraZeneca and Germany says Israel is part of the EU for this deal.

The 30 Arab local authorities and cities in Israel defined as high infection "red" a month ago have dwindled to just four. "Globes investigates how it was done.

Israel's coronavirus cabinet meets Tuesday to discuss what relaxations will be introduced. But fatalities have exceeded 2,000.

Tal Ohana did not sit around waiting for the government to act and has transformed Yeruham from a 'red' city to 'green' by taking responsibility for the situation.

Prof. Adam de la Zerda talks about the device that could be a game-changer in the fight against Covid-19.

Immunai helps drug companies make immune therapies more accurate and customized.

SaverOne claims to have the long-sought solution to drivers being distracted by their phones. Now it's up to the regulators.

Covid-19 has made sleep clinics risky, which is where Itamar Medical's disposable home sleep apnea diagnosis kit comes in.

Complex systems expert Dr. Yaneer Bar-Yam believes "flattening the curve" is immoral and futile, and that we have a better choice.

As Covid-19 rages, companies with solutions meet hospitals with problems on digital health community platform HealthIL.

In opposition, Naftali Bennett has gained popularity with policies to combat the virus, and is unscathed from his role in the government, which opened the economy.

The Intel SVP tells "Globes" that the million Israelis with underlying conditions who are endangered by Covid-19 should be given special protection.

MSD executive Dr. Eliav Barr describes his company's coronavirus vaccine strategy, and possible threats to come.

Founder Gil Kerbs tells "Globes" about Newt and its personalized nutrition app, which provides motivation as well as menus.

Good results, falling debt and Covid-19 have all contributed to the Israeli drugmaker's share price nearly doubling since March.

Former Prime Minister Ehud Olmert, a consultant to medical cannabis firm Univo, regrets the delay on export permits.